Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
2
×
life sciences
national blog main
achaogen
adams street partners
antibiotics
bayer
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston
boston blog main
boston top stories
cronos group
drug resistance
drugs
fda
ginkgo bioworks
hatteras venture partners
hyperammonemia
investing
james collins
liver diseases
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
neurological diseases
new enterprise associates
new york blog main
phenylketonuria
rempex pharmaceuticals
san diego
san diego blog main
san diego top stories
spero therapeutics
stanford university draper fund
startups
What
bacteria
2
×
company
medicines
biology
biopharma
bioworks
business
called
comprised
developer
disease
drug
engineered
exited
fighting
ginkgo
infections
infectious
lands
launches
living
melinta
products
qpex
ramp
resistant
sold
synlogic
synthetic
tackle
teaming
therapeutics
year
Language
Current search:
deals
×
bacteria
×
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections